| Dear Voornaam
We believe in the power of discovery to beat cancer, in supporting the individuals and teams who can push the boundaries of our understanding today and in developing the next generation who can continue making discoveries in the years ahead.
A key element of our strategy is to strengthen the UKs position as a world-leading destination for discoveries, in life sciences, cancer and innovation.
Later this year, we will publish a Manifesto for Cancer Research and Care which sets out clear, actionable policy proposals ahead of the next Westminster elections.
Its vital that our calls are relevant and grounded in evidence, and this is where you can help. Over the next few weeks, well be releasing a series of surveys around themes such as global collaboration, the clinical research environment, and access to health data for research. Through these, we want to gather your insights to build into our policy recommendations, so they can have the most impact on the research environment and outcomes for everyone affected by cancer.
In the first survey, wed like to hear how Brexit has impacted your research and about your priorities for global collaboration. This will help us to develop policy calls around reducing barriers and increasing opportunities for new and ongoing collaborations. We also welcome input from your colleagues, collaborators and anyone you work with across research operations, so please share as widely as possible within your network.
Thank you in advance for your support. Here is a link to our first survey.
Kind regards,
Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons
Cancer Research UK |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
ONE-DAY WORKSHOP TO IMPROVE CANCER PREVENTION APPROACHES Join us on 11 July for a workshop to discuss the opportunities and needs for developing better biological model systems to enable precision prevention approaches.
The event at the Royal Society will bring together cancer biologists, population researchers and clinicians, and we encourage early detection researchers from all career stages to attend.
During themed roundtable discussions and networking breaks you can explore potential new collaborations and research ideas in the prevention sphere. |
|
|---|
|
|---|
|
|
 SHOWCASE YOUR WORK AT OUR EARLY DETECTION OF CANCER CONFERENCE Are you an early career scientist interested or working in the field of early detection research?
You could be selected to speak alongside a line-up of international scientists including Patrick Bossuyt (University of Amsterdam), Jon Emery (University of Melbourne) and Fiona Gilbert (University of Cambridge).
Submit an abstract by 17 July to be considered for a lightning talk at the conference. All other submitted abstracts will feature as poster presentations. |
|
|---|
|  ACCESS SEED-FUNDING WITH CANCER RESEARCH HORIZONS Cancer Research Horizons, our innovation arm, is providing funding to researchers and early-stage startups to help advance innovative ideas in oncology.
Work with us and receive rapid access early-stage validation, pre-seed and seed capital, as well as access to commercial advice and guidance through our network of experts, mentors and management teams. Well support you with introductions to co-investors to maximise the chances of your ideas becoming financially attractive to investors. |
|
|---|
|
|---|
|
|
THAT CANCER CONVERSATION ON DIET AND CANCER METABOLISM As we start to understand the mechanisms behind nutrition and cancer, were realising that the current advice for patients may be counterproductive to their health, says our former chief scientist Karen Vousden.
In the latest episode of our podcast series That Cancer Conversation, Karen and Clare Shaw, a lead cancer dietician and therapy researcher, explore how food could improve cancer treatment.
Hear Karen and Clare discuss the advice and myths around diets during cancer treatment, how we could target cancer through metabolism and why precision nutrition could become the fourth pillar in cancer care, used in tandem with surgery, radiotherapy and therapeutics.
|
|
|---|
|
|---|
|
|
JOIN THE PRECISION MEDICINE WEBINAR FOR CHILDREN'S AND YOUNG PEOPLES CANCER Our next webinar in children's and young peoples cancer research brings together experts to explore the latest developments in precision medicine.
David OConnor will discuss improving precision with whole genome sequencing in childhood T-cell acute lymphoblastic leukaemia. Rob Pieters will share recent innovations in tailoring therapy for infants with acute lymphoblastic leukaemia, and Marilyn Li will delve into how multi-omics studies drive precision medicine in paediatric and young adult cancer care.
Join the webinar on 5 July at 45:30pm BST. |
|
|---|
|
|---|
|
|
 PRESENT YOUR WORK AT THE MAP 2023 CONGRESS Are you working in clinical and precision oncology and interested in showcasing your research to experts in the field?
Submit an abstract by 25 July for a chance to present your work as a poster presentation or be selected to join the speaker line-up and give a proffered talk at our leading precision oncology congress, MAP 2023.
There are also a limited number of travel grants available for first authors under the age of 40. |
|
|---|
|  INSPIRING THE NEXT GENERATION OF HEALTHTECH LEADERS KQ Labs is an accelerator programme run by the Francis Crick Institute for early-stage startups using data as a core part of their business model to improve human health.
Cancer Research Horizons is sponsoring one promising early-stage startup focused on cancer to join the programme. The accelerator programme will provide you with cohort-specific mentoring workshops covering a breadth of topics including fundraising, pitch training, business models and market access, as well as 40k funding in the form of a convertible loan. |
|
|---|
|
|---|
|
|
A WEBINAR ON RARE CANCER TUMOUR MODELS The International Rare Cancers Initiative is hosting a webinar on rare tumour PDX models on Tuesday 13 June, 910pm BST.
James Doroshow from the National Cancer Institute will take you through the initiatives work on patient-derived and rare tumour models and how they evaluate novel drug combinations for use in clinical trials for patients with rare cancers. At the end of the session, you can take part in an interactive discussion with James and three international experts from the rare cancer research community. |
|
|---|
|
|---|
|
|
ARE YOU ATTENDING THE EACR 2023 CONGRESS? Were looking forward to seeing you at the Annual Congress of the European Association for Cancer Research in Torino next week and hearing about the latest in basic, preclinical and translational research.
If you're presenting a poster or speaking at the conference, let us know and we'll give you a shout out on our social accounts. |
|
|---|
|
|---|
|
|
| | | Online 09:00 PM 13 June 2023 |
|
|---|
|
|---|
| | | Online 1:00 PM 20 June 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 05 July 2023 |
|
|---|
|
|---|
| | | London, UK 10:00 AM 11 July 2023 |
|
|---|
|
|---|
| | | London, UK 11 September 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | Paris, France 04 October 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
